Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Dylan Burzinski
Period: Reporting periods mapped to calendar 2024 Q4 – 2026 Q2 (7 quarters).
- Questions
- 15on tracked calls
- Challenge rate
- 13%2 of 15 questions
- Companies
- 2questioned at least once
- Reporting periods
- 7with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 15 of 15 questions from 2 companies
AREAlexandria Real Estate Equities9 questions · 6 reporting periods · 1 of 9 challenging
Calendar 2026 Q2
I assume they're no longer slated for redevelopment, but maybe if you can talk about the plan there
Show response
Marc said the redevelopment-acquired assets are being targeted at advanced technology tenants given ceiling heights and power access, with strong activity in Boston, San Francisco and Seattle. The 'other' bucket includes assets like Technology Square 200 needing capital upgrades.
Calendar 2026 Q1
is that sort of a good, call it, 3.5 million to 4 million square feet of annualized leasing volume a good amount to sort of use as a run rate
Show response
Joel cautioned against using Q2 as a run rate, noting the life science/advanced tech mix makes historical comparisons difficult. Historically ~1M sqft per quarter has been common, but the current environment is different.
the likelihood or probability of that $97.5 million moving higher as we get closer to '27
Show response
Marc said it is too early to predict retention rates on the remaining 1.5M sqft of 2027 expirations beyond the known vacates. For 2026 at Investor Day, they assumed 60%+ retention on normal-course expirations.
Calendar 2025 Q3
it seems like the only thing that's necessarily changed this quarter versus last quarter is really related to the government shutdown, right
Show response
Joel clarified the shutdown is a prerequisite but not the sole driver. Hallie added that tour activity shows great companies looking but decisions remain elongated due to regulatory and macro uncertainty.
is there any desire to sell a partial interest in any of the Megacampuses given it still seems like there'd be a strong bid
Show response
Joel stated the core strategy is to own more Megacampus rather than less, and the key plan is to rid the balance sheet of non-income-producing property and reduce non-core asset exposure.
Calendar 2025 Q2
is that more representative of change in cap rates across the property sector or more so related to just the types of assets you guys are selling
Show response
Peter explained higher cap rates reflect transitional non-core assets with lease rollover risk, not core mega campus values.
Calendar 2025 Q1
are there certain idiosyncratic things across the life science industry that you think is causing more of this conservatism
Show response
Joel said headwinds are both macro (tariffs, rates, budget) and industry-specific (NIH, FDA, HHS), with agency heads making good decisions despite broader turmoil.
Calendar 2024 Q4
new development leasing economics have deteriorated given the supply pipeline and drop off in demand. So just curious, sort of as you think about the current environment
Show response
Peter noted TIs remain 50% above pre-COVID levels with turnkey demand the norm, but free rent and concessions are stabilizing and the team believes fundamentals are reaching bottom.
are you seeing institutional real estate firms come back and kick the tires in terms of deploying capital in sector
Show response
Peter said institutional capital wants life science exposure but has learned to focus on experienced operators like Alexandria rather than inexperienced developers.
BXPBXP, Inc.6 questions · 6 reporting periods · 1 of 6 challenging
Calendar 2026 Q2
any possibility that the ultimate goal ends up being much higher than that $1.9 billion?
Show response
Named the three remaining buckets (entitled land, stabilized apartments, unstabilized office) and said the cadence will slow.
Calendar 2025 Q4
how much longer you guys would expect this sort of return to office movement to continue driving leasing activity
Show response
Owen said room to improve on office visits and earnings growth is the primary leasing driver, with 2026 corporate earnings growth accelerating above 2025. Doug differentiated: financial services and legal expansion is genuine headcount growth not return-to-office. Jake noted Reston defense/cybersecurity demand driven by tech talent concentration.
Calendar 2025 Q3
Why not sort of put the brakes on reaching out and getting the capital partner given that sort of backdrop
Show response
Owen said BXP is being patient with preliminary conversations from inbound interest. Asset is appreciating with leasing success and improving markets. Capital commitment should match equity raise timing, with draws accelerating in 2026. Doug noted the three objectives (earnings growth, fund 343, reduce leverage) all support finding a partner.
Calendar 2025 Q2
it seems like there's a clear path here to BXP's in-service portfolio level occupancy as it sits today to get to, call it, 90% plus occupancy in short order
Show response
Doug confirmed 90%+ is the expectation with signed leases not yet commenced, pipeline activity focused on 2026-2027 expirations which are very low, and sustained leasing volume supporting meaningful occupancy gains.
Calendar 2025 Q1
at what point of the downsizing cycle for a lot of these tenants on the West Coast, do you think we're in
Show response
Doug differentiated SF CBD (minimal incremental downsizing) from Silicon Valley (large tech still has excess capacity). Hilary noted large tech stable in Manhattan with Meta taking sublease space off market. Bryan cited Boston clients needing more focused work areas.
Calendar 2024 Q4
are you guys starting to be able to push face rent so that on a net effective basis, we're starting to see incremental improvement
Show response
Doug confirmed rents rising in Midtown and Back Bay, with double-digit increases on Park Avenue. Cautioned against expecting portfolio-wide rental rate increases. Mike noted no new supply coming in 2026-2027.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| ARE Alexandria Real Estate Equities | 9 | 11%1 of 9 questions |
| BXP BXP, Inc. | 6 | 17%1 of 6 questions |
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2024 Q4 | 3 | 33%1 of 3 questions | 2 |
| 2025 Q1 | 2 | 0%none of 2 questions | 2 |
| 2025 Q2 | 2 | 0%none of 2 questions | 2 |
| 2025 Q3 | 3 | 33%1 of 3 questions | 2 |
| 2025 Q4 | 1 | 0%none of 1 question | 1 |
| 2026 Q1 | 2 | 0%none of 2 questions | 1 |
| 2026 Q2 | 2 | 0%none of 2 questions | 2 |
- 2024 Q43 questions · challenge rate 33% (1 of 3 questions) · 2 companies
- 2025 Q12 questions · challenge rate 0% (none of 2 questions) · 2 companies
- 2025 Q22 questions · challenge rate 0% (none of 2 questions) · 2 companies
- 2025 Q33 questions · challenge rate 33% (1 of 3 questions) · 2 companies
- 2025 Q41 question · challenge rate 0% (none of 1 question) · 1 company
- 2026 Q12 questions · challenge rate 0% (none of 2 questions) · 1 company
- 2026 Q22 questions · challenge rate 0% (none of 2 questions) · 2 companies
Topics
Topics tagged on this analyst’s questions.
- Demand7
- Capital Allocation5
- Competitive Dynamics3
- Capex Investment2
- Regulation Policy2
- Revenue Growth2
- Pricing2
- M&A1
- Labor Market1
- Macroeconomic1